Attention: This platform is in beta mode. Expect some changes and adjustments.

AI Market Mood: Stock Dashboard

ADVM


Fundamental

Company: Adverum Biotechnologies Inc
Sector: Healthcare
Industry: Biotechnology
Country: USA
Exchange: NASD
Index: -
P/E: -
EPS (ttm): -6.39
Insider Own: 33.78%
Shs Outstand: 20.89M
Perf Week: -4.33%
Market Cap: 55.36M
Forward P/E: -
EPS next Y: -3.16
Insider Trans: 14.32%
Shs Float: 13.83M
Perf Month: 2.71%
Enterprise Value: 65.46M
PEG: -
EPS next Q: -2.25
Inst Own: 58.36%
Short Float: 7.47%
Perf Quarter: -10.77%
Income: -133.56M
P/S: 55.36
EPS this Y: 13.85%
Inst Trans: 0.64%
Short Ratio: 2.87
Perf Half Y: -41.24%
Sales: 1.00M
P/B: 2.10
EPS next Y Percentage: 44.59%
ROA: -65.88%
Short Interest: 1.03M
Perf YTD: -43.25%
Book/sh: 1.26
P/C: 0.67
EPS next 5Y: 19.86%
ROE: -127.99%
52W High: 8.58 -69.11%
Perf Year: -66.20%
Cash/sh: 3.98
P/FCF: -
EPS past 3/5Y: 23.61% 8.03%
ROIC: -118.86%
52W Low: 1.78 48.88%
Perf 3Y: -84.77%
Dividend Est.: -
EV/EBITDA: -
Sales past 3/5Y: -48.91% 31.95%
Gross Margin: -233.90%
Volatility W: 8.09%
Volatility M: 8.77%
Perf 5Y: -98.48%
Dividend TTM: -
EV/Sales: 65.46
EPS Y/Y TTM: 37.54%
Oper. Margin: -15364.20%
ATR (14): 0.21
Perf 10Y: -98.41%
Dividend Ex-Date: -
Quick Ratio: 3.57
Sales Y/Y TTM: -72.22%
Profit Margin: -13356.00%
RSI (14): 52.46
Recom: 1.33
Dividend Gr. 3/5Y: - -
Current Ratio: 3.57
EPS Q/Q: -49.29%
SMA20: 4.23%
Beta: 0.79
Target Price: 19.75
Payout: -
Debt/Eq: 3.53
Sales Q/Q: -
SMA50: 8.00%
Rel Volume: 0.10
Prev Close: 2.67
Employees: 155
LT Debt/Eq: 3.25
Earnings: May 14 AMC
SMA200: -40.63%
Avg Volume: 360.19K
Price: 2.65
IPO: Jul 31, 2014
Option/Short: Yes / Yes
EPS/Sales Surpr.: -15.98% -
Trades:
Volume: 21,518
Change: -0.75%

Technical:


Latest News:

Analysts' Top Healthcare Picks: Adverum Biotechnologies (ADVM), Gilead Sciences (GILD) somewhat bullish
ADVM GILD CVRX

Summary: Analysts are bullish on Adverum Biotechnologies (ADVM), Gilead Sciences (GILD), and CVRx (CVRX) in the Healthcare sector.

Full article
2025-02-13T15:11:42Z